On August 25, 2021, the 2021 ZONHONBIO and GENSUNBIO R & D Achievement Report Meeting and Annual R&D Department Mid-term Assessment hosted by the parent company ZONHONBIO and co-organized by GENSUNBIO was successfully held in the multi-purpose hall on the third floor. The leaders of the competent departments as well as the leaders and peers of QIANHONGBIO, who have been always caring about and supporting ZONHONBIO, attended the report meeting.

As the first issue of the report meeting, President • General Manager Mr. Ma Yong gave an overview of the 2021 ZONHONBIO and GENSUNBIO R & D Achievement Report Meeting and commended the 2021 ZONHONBIO and GENSUNBIO Annual Merit Award. Mr. Ma Yong first paid the highest respect to the leaders and peers who have been caring about and supporting ZONHONBIO and GENSUNBIO. He also expressed his most sincere gratitude to all the employees of ZONHONBIO and GENSUNBIO for their hard work and companionship over the years. Then, he reviewed the development of the company over the past ten years. With the accumulation of knowledge and technology and the accumulation of experience and lessons in the past ten years, ZONHONBIO has always been committed to the research and development of innovative drugs, and has achieved gratifying breakthrough and results. GENSUNBIO focuses on the application and R & D in the fields of biomedicine and medical aesthetics for a long time, consolidating the innovative R & D of biomedical and medical aesthetics materials and products with independent intellectual property rights. At the same time, substantial progress has been made in the serial R & D of functional health food based on the homology of medicine and food. Mr. Ma Yong hoped that everyone would always bear in mind the original intention of innovative R & D, and continue to advance, inheriting the essence of the enterprise culture that ZONHONBIO pursues core competitiveness and GENSUNBIO pursues characteristic innovation source. At the meeting, Mr. Ma Yong referred to the Olympic spirit of "higher, faster, stronger and more united" in the Tokyo Olympics, and called on everyone to continue to overcome difficulties and forge ahead on the road of scientific research and innovation, making unremitting efforts for the next decade and the realization of GENSUN dream. Finally, he announced the award-winning employees of the "2021 ZONHONBIO and GENSUNBIO Annual Merit Award", and held the awarding and commendation ceremony.

After that, it came to the second meeting issue - Newcomer Forum and R&D Department Mid-term Assessment. In the newcomer forum, four R&D members who were recently employed reported and shared the staged progress of their own projects. In the mid-term assessment, 21 representatives of R&D and management departments reported the progress of R&D projects or management innovation. In the question-and-answer session, the leaders and peers communicated, discussed and interacted with each other. The academic atmosphere was strong at the meeting and interactions were active. After all the reports, the Excellent R&D Achievement Selection Committee of the company held a review meeting. Adhering to the principles of "innovation, completion, normalization, growth, practicality, influence, and fairness", a strict and fair comprehensive review was carried out. This report meeting finally selected two "2021 Excellent R&D Newcomer Awards" and six "2021 Excellent R&D Achievement Awards", of which GENSUNBIO 's employees won two awards with one each. The award ceremony was also held at the report meeting.

With the warm applause, the host announced the successful conclusion of the 2021 ZONHONBIO and GENSUNBIO R & D Achievement Report Meeting.

Special Note: This report meeting strictly complied with the relevant government regulations on epidemic prevention and control. Before entering the hall, all the participants had been confirmed by the conference staff that the Sukang code and itinerary code on the day were green and body temperature was normal. Everyone’s hands were disinfected with alcohol, and all the attendees kept wearing masks during the meeting.